The Post first wrote about Violet Law in May when her family was raising money for medical research. Recently, she qualified for a clinical trial into treatments for GM1 gangliosidosis.
After serving the public for 16 years, we are now in the hands of the community, where news belongs.
Support our work; become a member today. Be part of it.
The Post first wrote about Violet Law in May when her family was raising money for medical research. Recently, she qualified for a clinical trial into treatments for GM1 gangliosidosis.